comments
.
jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.
arabic
.
.
.
.
.
.